CXCL10 and COVID-19: Another study showed that COVID-19 convalescents at 4 months post infection had higher levels of IFN-β, IFN-λ1, CXCL9, CXCL10, IL-8, and sTIM-3, regardless of symptoms, compared to uninfected controls.